These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7999823)

  • 1. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
    Richards GK; Morcos RJ; Gagnon RF
    Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
    Gagnon RF; Richards GK; Kostiner GB
    Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative rates of antibiotic action against Staphylococcus epidermidis biofilms.
    Richards GK; Gagnon RF; Prentis J
    ASAIO Trans; 1991; 37(3):M160-2. PubMed ID: 1751091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms.
    Gualtieri M; Bastide L; Villain-Guillot P; Michaux-Charachon S; Latouche J; Leonetti JP
    J Antimicrob Chemother; 2006 Oct; 58(4):778-83. PubMed ID: 16880176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
    Yan Q; Karau MJ; Raval YS; Patel R
    Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin.
    Gagnon RF; Richards GK; Wiesenfeld L
    ASAIO Trans; 1991; 37(3):M158-60. PubMed ID: 1751090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dialysis fluid on the susceptibility of Staphylococcus epidermidis biofilms to rifampin.
    Gagnon RF; Richards GK; Kostiner GB; Morcos R
    Adv Perit Dial; 1993; 9():183-6. PubMed ID: 8105919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.
    Villain-Guillot P; Gualtieri M; Bastide L; Leonetti JP
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3117-21. PubMed ID: 17606690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of heparin on rifampin activity against Staphylococcus epidermidis biofilms.
    Gagnon RF; Harris AD; Prentis J; Richards GK
    Adv Perit Dial; 1989; 5():138-42. PubMed ID: 2577397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
    Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
    Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial coating agents: can biofilm formation on a breast implant be prevented?
    van Heerden J; Turner M; Hoffmann D; Moolman J
    J Plast Reconstr Aesthet Surg; 2009 May; 62(5):610-7. PubMed ID: 18359675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foreign body infections due to Staphylococcus epidermidis.
    Uçkay I; Pittet D; Vaudaux P; Sax H; Lew D; Waldvogel F
    Ann Med; 2009; 41(2):109-19. PubMed ID: 18720093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
    Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
    J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY; Ko KS; Peck KR; Oh WS; Song JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
    Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
    Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence gene expression by Staphylococcus epidermidis biofilm cells exposed to antibiotics.
    Gomes F; Teixeira P; Cerca N; Ceri H; Oliveira R
    Microb Drug Resist; 2011 Jun; 17(2):191-6. PubMed ID: 21395450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin.
    Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
    Am J Ther; 2013; 20(4):322-8. PubMed ID: 21519220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modulation by fresh and spent peritoneal dialysis fluids of antibiotic kinetics directed against Staphylococcus epidermidis biofilms.
    Richards GK; Kostiner GB; Gagnon RF
    Adv Perit Dial; 1992; 8():246-9. PubMed ID: 1361798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic activity against Staphylococcus epidermidis biofilms in dialysis fluids.
    Richards GK; Prentis J; Gagnon RF
    Adv Perit Dial; 1989; 5():133-7. PubMed ID: 2577396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.